Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 71 checked references that resolve
resolves10.3762/bjoc.14.64Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery
resolves10.1155/2012/967347Cancer Treatment Using Peptides: Current Therapies and Future Prospects
resolves10.1038/nbt1320Small antibody mimetics comprising two complementarity-determining regions and a framework region for tumor targeting
resolves10.3390/pharmaceutics10040223Enhanced In Vitro Antitumor Activity of GnRH-III-Daunorubicin Bioconjugates Influenced by Sequence Modification
resolves10.1002/ijc.2910540122Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation
resolves10.1038/nm0195-27Angiogenesis in cancer, vascular, rheumatoid and other disease
resolves10.1038/s41388-018-0213-4NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth
resolves10.1136/jcp.47.1.43Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin.
resolves10.1182/blood.V97.3.652CD13/APN is activated by angiogenic signals and is essential for capillary tube formation
resolves10.1016/j.canlet.2005.11.051Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis
resolves10.1053/gast.2002.31095Aminopeptidase N is involved in cell motility and angiogenesis: Its clinical significance in human colon cancer
resolves10.1117/1.2839046In vivo optical imaging of CD13/APN-expression in tumor xenografts
resolves10.1002/cncr.21149Addition of an aminopeptidase N‐binding sequence to human endostatin improves inhibition of ovarian carcinoma growth
resolves10.1089/104303404322959524Inhibition of Tumor Growth by Intramuscular Injection of cDNA Encoding Tumor Necrosis Factor
<i>α</i>
Coupled to NGR and RGD Tumor-Homing Peptides
resolves10.1182/blood-2008-04-150318Infarction of tumor vessels by NGR-peptide–directed targeting of tissue factor: experimental results and first-in-man experience
resolves10.1158/0008-5472.CAN-08-0689Quantitative Molecular Magnetic Resonance Imaging of Tumor Angiogenesis Using cNGR-Labeled Paramagnetic Quantum Dots
resolves10.1038/81183Enhancement of tumor necrosis factor α antitumor immunotherapeutic properties by targeted delivery to aminopeptidase N (CD13)
resolves10.1038/12469Anti-cancer activity of targeted pro-apoptotic peptides
resolves10.1158/0008-5472.CAN-06-2117Targeting Liposomal Chemotherapy via Both Tumor Cell–Specific and Tumor Vasculature–Specific Ligands Potentiates Therapeutic Efficacy
resolves10.1021/bc070031kConjugated Platinum(IV)−Peptide Complexes for Targeting Angiogenic Tumor Vasculature
resolves10.1039/b417734gSynthesis and photochemical properties of photoactivated antitumor prodrugs releasing 5-fluorouracil
resolves10.3390/ijms18020429Succinimide Formation from an NGR-Containing Cyclic Peptide: Computational Evidence for Catalytic Roles of Phosphate Buffer and the Arginine Side Chain
resolves10.1007/BF01024992Formation of isoaspartate 99 in bovine and porcine somatotropins
resolves10.1016/S0021-9258(19)75855-4Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation.
resolves10.1021/jm501630jDevelopment of Cyclic NGR Peptides with Thioether Linkage: Structure and Dynamics Determining Deamidation and Bioactivity
resolves10.1074/jbc.M109.044297Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching
resolves10.1074/jbc.M710273200Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin
resolves10.1002/anie.201004363Conformational Control of Integrin‐Subtype Selectivity in <i>iso</i>DGR Peptide Motifs: A Biological Switch
resolves10.3762/bjoc.14.78Development of novel cyclic NGR peptide–daunomycin conjugates with dual targeting property
resolves10.1242/bio.2012364Matched rabbit monoclonal antibodies against αv-series integrins reveal a novel αvβ3-LIBS epitope, and permit routine staining of archival paraffin samples of human tumors
resolves10.1111/j.1365-2133.2000.03709.xPhenotypic characteristics of Kaposi's sarcoma tumour cells derived from patch-, plaque- and nodular-stage lesions: analysis of cell cultures isolated from AIDS and non-AIDS patients and review of the literature
resolves10.1016/j.tcb.2013.04.001Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming
resolves10.1097/00002030-199706000-00003The β-core fragment of human chorionic gonadotrophin inhibits growth of Kaposiʼs sarcoma-derived cells and a new immortalized Kaposiʼs sarcoma cell line
resolves10.1007/BF01756387Expression and role of integrins in adhesion of human colonic carcinoma cells to extracellular matrix components
resolves10.1128/JVI.01673-07Integrin α
<sub>V</sub>
β
<sub>3</sub>
Binds to the RGD Motif of Glycoprotein B of Kaposi's Sarcoma-Associated Herpesvirus and Functions as an RGD-Dependent Entry Receptor
resolves10.1016/S1359-6101(97)00037-3Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents
resolves10.1128/JVI.01334-09Early Events in Kaposi's Sarcoma-Associated Herpesvirus Infection of Target Cells
resolves10.1182/blood.V84.8.2711.2711Identification and culture of Kaposi's sarcoma-like spindle cells from the peripheral blood of human immunodeficiency virus-1-infected individuals and normal controls [see comments]
resolves10.1002/anie.201007091Use of Metadynamics in the Design of isoDGR‐Based αvβ3 Antagonists To Fine‐Tune the Conformational Ensemble
resolves10.1007/s00726-010-0766-1In vitro degradation and antitumor activity of oxime bond-linked daunorubicin–GnRH-III bioconjugates and DNA-binding properties of daunorubicin–amino acid metabolites
resolves10.1007/s10637-016-0354-7Improved in vivo antitumor effect of a daunorubicin - GnRH-III bioconjugate modified by apoptosis inducing agent butyric acid on colorectal carcinoma bearing mice
resolves10.1016/j.ejmech.2019.05.016Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems
resolves10.3390/ijms20194763Improved In Vivo Anti-Tumor and Anti-Metastatic Effect of GnRH-III-Daunorubicin Analogs on Colorectal and Breast Carcinoma Bearing Mice
The 10 references without a DOI — listed, not checked
no DOI — not checkedWang RE, Niu Y, Wu H, Amin MN, Cai J (2011) Development of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol Imaging 1(1):36–46
no DOI — not checkedMenrad A, Speicher D, Wacker J, Herlyn M (1993) Biochemical and functional characterization of aminopeptidase N expressed by human melanoma cells. Cancer Res 53(6):1450–1455
no DOI — not checkedChen H, Kinzer CA, Paul WE (1996) p161, a murine membrane protein expressed on mast cells and some macrophages, is mouse CD13/aminopeptidase N. J Immunol Baltim Md 157(6):2593–2600
no DOI — not checkedDrexler HG (1987) Classification of acute myeloid leukemias--a comparison of FAB and immunophenotyping. Leukemia 1(10):697–705
no DOI — not checkedMáté G, Kertész I, Enyedi KN et al (2015) In vivo imaging of aminopeptidase N (CD13) receptors in experimental renal tumors using the novel radiotracer (68)Ga-NOTA-c(NGR). Eur J Pharm Sci Off J Eur Fed Pharm Sci 69:61–71
no DOI — not checkedCorti A (2004) Strategies for improving the anti-neoplastic activity of TNF by tumor targeting. Methods Mol Med 98:247–264
no DOI — not checkedCorti A, Curnis F, Rossoni G, Marcucci F, Gregorc V (2013) Peptide-mediated targeting of cytokines to tumor vasculature: the NGR-hTNF example. BioDrugs Clin Immunother Biopharm Gene Ther 27(6):591–603
no DOI — not checkedMingozzi M, Dal Corso A, Marchini M et al (2013) Cyclic isoDGR peptidomimetics as low-nanomolar αvβ3 integrin ligands. Chem Weinh Bergstr Ger 19(11):3563–3567
no DOI — not checkedKuntzman R, Mark LC, Brand LC et al (1966) Metabolism of drugs and carcinogens by human liver enzymes. J Pharmacol Exp Ther 152(1):151–156
no DOI — not checkedHirst DG, Denekamp J (1979) Tumour cell proliferation in relation to the vasculature. Cell Tissue Kinet 12(1):31–42
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.